Pluri Inc. Intangible Assets, Net (Excluding Goodwill)
Pluri Inc. (PLUR) had Intangible Assets, Net (Excluding Goodwill) of $2.70 million as of 2025-12-31, per its 10-Q filed 2026-02-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-02-12
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $2.70M.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $2.75M.
- 2025-06-30: Intangible Assets, Net (Excluding Goodwill) $2.79M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2025-12-31 | $2.70M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $2.75M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.79M 10-Q · filed 2026-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |